This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q92829395
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована 17 серпня 2019 scientific article published on 17 August 2019 artículu científicu espublizáu n'agostu de 2019 article scientifique publié en 2019 wetenschappelijk artikel
p:P577
wds:Q92829395-DC70502A-3BDA-4609-9876-C67DF28B2A05
wdt:P577
2019-08-17T00:00:00Z
rdfs:label
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
skos:prefLabel
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
schema:name
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
p:P50
wds:Q92829395-E7D8FE3D-C6B8-468C-B764-CBB192494019 wds:Q92829395-E9C22A2F-3CEB-4D93-9C12-E3BA8797D38A wds:Q92829395-FAD9E319-7C1D-47ED-9C36-16CA9F3A22E1 wds:Q92829395-7A3FF0E9-C499-4FBB-B375-54CDFD6EED95 wds:Q92829395-7FC715F7-5297-4241-B24C-97A51B477231 wds:Q92829395-996E0292-33EB-4F8D-B2C3-D32FDCDA7276 wds:Q92829395-B48C5053-376B-4A7E-9B4C-28135C21A060 wds:Q92829395-B9379EE5-DC4B-4187-A537-A7D527EF2C5A wds:Q92829395-49221E6A-D1E5-4D3E-88DB-A23D147E3D81 wds:Q92829395-4D5DD1C2-EAE5-4E76-80BA-41449AED6165 wds:Q92829395-621DB643-3730-45B3-92A2-3D289F97E389 wds:Q92829395-7958830F-961A-44CE-AAC9-25C1292958DA wds:Q92829395-25B70BFD-81E7-4B47-B14D-3D31BAAD0F5D wds:Q92829395-3E5393E7-4A3B-4E01-858D-9A19F81FE5FC
wdt:P50
wd:Q114436560 wd:Q114371072 wd:Q114783201 wd:Q114783191 wd:Q37386651 wd:Q114783219 wd:Q107986252 wd:Q114783220 wd:Q114783218 wd:Q114439136 wd:Q57330452 wd:Q92482942 wd:Q114436490 wd:Q114436440
p:P1476
wds:Q92829395-B943F432-338D-4E88-BBA2-017F54FCC2E7
wdt:P1476
Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fraction
p:P304
wds:Q92829395-6A988127-95A8-4369-8D99-C427A44B987C
wdt:P304
91-97
p:P31
wds:Q92829395-DA7C8FE1-870B-40E3-872C-394A183D1E51
wdt:P31
wd:Q13442814
p:P921
wds:Q92829395-855BDCEE-4252-47E6-B206-B297D80DC152
wdt:P921
wd:Q641303
p:P698
wds:Q92829395-E0799F35-5D7E-4BBB-961C-82D3B77820C8
wdtn:P698
n9:31443984
wdt:P698
31443984
p:P1433
wds:Q92829395-6AB164AE-84F9-4819-A8C1-3BC69DBBA8C0
wdt:P1433
wd:Q2357863
p:P478
wds:Q92829395-57D831A2-A6BA-41B3-92D8-9AE149C2D5EF
wdt:P478
296
p:P356
wds:Q92829395-5EEF9B7B-4EAA-45C0-86D2-EBD3A14B849C
wdtn:P356
n12:J.IJCARD.2019.08.040
wdt:P356
10.1016/J.IJCARD.2019.08.040